Market Overview

The Global Lung Cancer Surgery Market was valued at USD 6,075.8 million in 2023 and is expected to reach USD 8,463.4 million by 2031 while growing at a CAGR of 4.2% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global lung cancer surgery market growth. Lung cancer surgery involves removing tumors or cancerous tissues from the lungs to eliminate or reduce cancer cell presence. It is a vital part of comprehensive lung cancer treatment plans and is often combined with chemotherapy and radiation therapy based on the cancer stage and type.

The increasing incidence of lung cancer, coupled with technological advancements and improved healthcare infrastructure, is driving substantial growth in the lung cancer surgery market. Despite these positive factors, the market expansion may encounter hurdles such as the risk of surgical complications and the high cost of lung cancer treatment.

Furthermore, the global lung cancer surgery industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Lung Cancer Surgery Market is segmented among Thoracotomy, and Minimally Invasive Surgeries, based on type. In 2023, Thoracotomy accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product Analysis

The Global Lung Cancer Surgery Market is segmented among Surgical Devices, and Monitoring Devices, based on product. In 2023, Surgical Devices accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Lung Cancer Surgery Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Accuray Incorporated, GE Healthcare, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers AG, and AngioDynamics Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Lung Cancer Surgery Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Lung Cancer Surgery Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Lung Cancer Surgery Market Segmentation, By Type

• Global Lung Cancer Surgery Market Share Analysis, By Type

• Global Lung Cancer Surgery Market Growth Analysis, By Type

• Global Lung Cancer Surgery Market Trends, By Type

o Thoracotomy

Ø Lobectomy

Ø Sleeve Resection

Ø Segmentectomy

Ø Pneumonectomy

o Minimally Invasive Surgeries

6. Global Lung Cancer Surgery Market Segmentation, By Product

• Global Lung Cancer Surgery Market Share Analysis, By Product

• Global Lung Cancer Surgery Market Growth Analysis, By Product

• Global Lung Cancer Surgery Market Trends, By Product

o Surgical Devices

o Monitoring Devices

7. Global Lung Cancer Surgery Market Segmentation, By Region

• Global Lung Cancer Surgery Market Share Analysis, By Region

• Global Lung Cancer Surgery Market Growth Analysis, By Region

• Global Lung Cancer Surgery Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Accuray Incorporated*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• GE Healthcare

• Johnson & Johnson

• Olympus Corporation

• Richard Wolf GmbH

• Siemens Healthineers AG

• AngioDynamics Inc.

*Similar analysis will be provided for each company listed above.